ConductScience.org, home

Paper · 41575482

Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review.

Tzeravini E and 4 others. Curr Obes Rep, 2026. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review. Papers, record 41575482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41575482

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review.
PubMed
Journal
Curr Obes Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-06-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tzeravini EEvangeliahttps://orcid.org/0000-0002-6805-5206
2Simati SStamatiahttps://orcid.org/0009-0005-8481-3678
3Anastasiou IAIoanna Ahttps://orcid.org/0000-0002-7560-0575
4Dalamaga MMariahttps://orcid.org/0000-0002-7008-388X
5Kokkinos AAlexanderhttps://orcid.org/0000-0002-5491-2545

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
ObesityMajor topic
Gastrointestinal HormonesMajor topic
Gastrointestinal TractMajor topic
Humans
Postprandial Period
Peptide YY
Gastric Inhibitory Polypeptide
Oxyntomodulin
Ghrelin
Glucose Tolerance Test
Glucagon-Like Peptide 1

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References257

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124,161,075Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.Annu Rev Physiol2014https://conductscience.org/library/papers/24161075PubMed
233,524,152Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.J Clin Endocrinol Metab2021https://conductscience.org/library/papers/33524152PubMed
3400,768Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin.J Clin Endocrinol Metab1978https://conductscience.org/library/papers/400768PubMed
436,509,169Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes.Peptides2023https://conductscience.org/library/papers/36509169PubMed
5775,874Secretin-induced insulin response. II. Dose-response relation.Acta Endocrinol (Copenh)1976https://conductscience.org/library/papers/775874PubMed
61,756,902Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.Diabetes1991https://conductscience.org/library/papers/1756902PubMed
735,327,658Assessment of Two Different Glucagon Assays in Healthy Individuals and Type 1 and Type 2 Diabetes Patients.Biomolecules2022https://conductscience.org/library/papers/35327658PubMed
830,572,349Gut Hormone Responses to Mixed Meal Test in New-Onset Prediabetes/Diabetes After Acute Pancreatitis.Horm Metab Res2019https://conductscience.org/library/papers/30572349PubMed
934,929,379Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus.Diabetes Metab2022https://conductscience.org/library/papers/34929379PubMed
1018,773,927Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas.Regul Pept2009https://conductscience.org/library/papers/18773927PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42,131,480GLP-1 receptor and Mitochondria-ER Contact Sites: an emerging mechanism of metabolic regulation.Front Physiol2026https://conductscience.org/library/papers/42131480PubMed
41,751,766Precision Nutrition in Type 2 Diabetes Prevention Through Molecular Nutrigenomic and Epigenetic Modulation of Insulin Signaling and Glucose Metabolism.Int J Mol Sci2026https://conductscience.org/library/papers/41751766PubMed

Genes34

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41575482

GET https://conductscience.org/api/papers/v1/41575482/references?page=2